NewsMarketsIsraeli Company Floats On Canadian Market

Israeli Company Floats On Canadian Market

-

AFTER securing around $15m to boost its European operations IM Cannabis has become the first Israeli company to list its shares in Canada.

International Medical Cannabis (IMC) will trade under the ticker ‘IMCC’ on the Canadian Securities Exchange and may well be the first of many Israeli companies to follow this path.

Israeli daily financial website Calcalist recently reported on an anticipated flow of domestic companies to Canada.

With cannabis being legal in Canada it affords ambitious firms proximity to some of the leading global cannabis companies and access to an established cannabis-savvy financial system.

IMC has global ambitions with an keen focus on the European market and it will use the proceeds of a successful $15m private fund-raising round to bolster its footprint in Germany, Portugal and Greece

Oren Shuster, Chief Executive Officer, said it was doing ‘exceptionally well to position the company as a market leader in the EU’.

He said its European expansion strategy includes operations in Germany, a supply agreement in Europe, and will soon include operations in Portugal and Greece

IMC says it views the German market as particularly attractive given its size, regulatory structure and proximity to Israel, and earlier this year it purchased Adjupharm a German EU-GMP manufacturer and distributor. 

This business has licenses to import, export and distribute medical cannabis in Germany and has been distributing medical products to pharmacies for over 10 years, says IMC.



Peter
Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest news

Thought Leaders Acquisition Of mellow Set To Accelerate Growth Across UK, Europe, And Asia Footprint

THE CBD world is set with a massive shake-up this week as Thought Leaders, the US cannabis & CBD investment company,...

Medical Cannabis Cost-Benefit Analysis Set To Be Launched By UK CIC At A Cost of £30,000

THE initial priorities of the UK Cannabis Industry Council have been identified following a special general meeting attended by...

CIC Research Group Looking To Overcome The ‘Scandalous’ Impasse On UK Medical Cannabis Prescribing

Chartered Psychologist and Head of Research at Drug Science, Dr Anne Katrin Schlag, heads up the newly formed Cannabis...

European Cannabis Market Leader Bloomwell Group Secures $10m Investment

The Bloomwell Group has successfully closed a seed funding round of over $10 million dollars—the highest publicly known seed investment...

German Hemp Farm Numbers Up 900% In Seven Years – As industry Calls For Post-Election Reform

THE number of German farms growing industrial hemp has hit 863 – the highest figure since the federal republic...

US Company Set To Launch UK Medical Cannabis Study In Partnership With Manchester University

A GROUND-BREAKING human pilot study centred on the University of Manchester could provide answers to using cannabis as a...

Must read

Medical Cannabis Cost-Benefit Analysis Set To Be Launched By UK CIC At A Cost of £30,000

THE initial priorities of the UK Cannabis Industry Council...

CIC Research Group Looking To Overcome The ‘Scandalous’ Impasse On UK Medical Cannabis Prescribing

Chartered Psychologist and Head of Research at Drug Science,...

You might also likeRELATED
Recommended to you